Sanyou Biopharmaceuticals completes series B financing and secures its leading role in innovative antibody drug discovery

SHANGHAI, June 26, 2021 /PRNewswire/ — Sanyou Biopharmaceutical (Shanghai) Co., Ltd. (hereafter referred to as “Sanyou Bio” or “the Company”), a leading company in innovative antibody drug discovery, announced the closing of series B financing. This financing round was co-led